The novel approach of the medication represents a major breakthrough in the handling of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide234580.bloggosite.com/49989525/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment